No Data
No Data
Zhitong Hong Kong Stock Exchange Unravels | A-shares make up gains and continues to boost Hong Kong stocks need to be wary of attacking Rafah
The current problem with Hong Kong stocks is nothing more than a matter of profit digestion, but under the stimulus of the money-making effect, the entry of incremental capital is expected to form a hedge
Hong Kong stocks closed (05.06) | The Hang Seng Index closed up 0.55% to reap the Shilianyang CRO concept, strong high-speed rail infrastructure stocks, and domestic housing stocks fell across the board
The US non-farm payrolls data for April fell short of expectations, and expectations of market interest rate cuts rebounded somewhat. Hong Kong stocks bottomed out and rebounded today. The three major indices all turned red. The Hang Seng Index successfully reaped 10 consecutive days, and the Hengke Index also reached the 4,000 point mark.
Trending Industry Today: WUXI BIO Leads Gains In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
May 6th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending higher today with 8 constituents up, 1 constituents down and WUXI BIO leading
Direct impact of changes | Yao Ming Biotech rose more than 7% to lead CRO concept stocks. The Federal Reserve may still cut interest rates during the year, and overseas demand is expected to resume
On May 6, CRO concept stocks had the highest gains in early trading. As of press release, Tiger Pharmaceuticals (03347) rose 6.82% to HK$36.8; Pharmaceutical Biotech (02269) rose 5.87% to HK$36.45; Kanglong Chemical (03759) rose 4.92% to HK$10.44; and Pharmaceuticals Kangde (02359) rose 3.14% to HK$37.75.
Changes in Hong Kong stocks | CRO concept stocks fell across the board, Yakming Kangde (02359) fell more than 7%, leading the decline, and the company's profit margin for the first quarter fell short of expectations
CRO concept stocks fell across the board. As of press release, Yao Ming Kangde (02359) fell 6.47% to 36.15 yuan; Gloria Ying (06821) fell 5.33% to 63.05 yuan; Kanglong Chemical (03759) fell 4.96% to HK$9.96.
Tiger Pharmaceuticals (03347) plans to spend 500 million to 1 billion yuan to buy back no less than 13.8889 million shares
Tiger Pharmaceuticals (03347) issued an announcement. The company announced on February 6, 2024 and April 12, 2024, respectively...
No Data